From the 10Q: "Incorporating the FDA's guidance
Post# of 148165
(Total Views: 1017)
Posted On: 01/19/2024 10:43:11 PM
From the 10Q:
"Incorporating the FDA's guidance by the end of January 2024.
(Trial Protocol)
Quantitative and Qualitative disclosures about market risk
(No material changes from the 2023 form 10K).
Controls and Procedures were effective
(at the reasonable assurance level).
Safe to say,...All is well in Hell.
"Incorporating the FDA's guidance by the end of January 2024.
(Trial Protocol)
Quantitative and Qualitative disclosures about market risk
(No material changes from the 2023 form 10K).
Controls and Procedures were effective
(at the reasonable assurance level).
Safe to say,...All is well in Hell.
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼